You are using an outdated browser and your browsing experience will not be optimal. Please update to the latest version of Microsoft Edge, Google Chrome or Mozilla Firefox. Install Microsoft Edge

May 21, 2020

Atthachai Homhuan and Kittiya Nopparatrungroj Speak on New Normal in Pharma and Medical Devices

Subscribe to Updates

On May 21, Dr. Atthachai Homhuan, manager of regulatory affairs in Tilleke & Gibbins’ Bangkok office, and Kittiya Nopparatrungroj, consultant and licensed pharmacist, will join together to present a webinar cohosted by Tilleke & Gibbins and the Thai Listed Companies Association (TLCA).

Their session, entitled “New Normal in Pharma and Medical Devices: The Impact of COVID-19,” will dive into the responses to the COVID-19 outbreak by the Thai Food and Drug Administration and the Department of Internal Trade, and how government policy may affect the production and distribution of personal protective equipment, medical devices, and pharmaceutical products. Immediately following the webinar, Atthachai and Kittiya will respond to attendee questions through a brief Q&A session.

The webinar, which will be conducted in Thai language, will go live on Thursday, May 21, at 2:00 p.m. If you’re interested in attending, please register for the webinar by sending an email to [email protected].

RELATED PROFESSIONALS

Industries

Life Sciences

Practices

Regulatory Affairs

Location

RELATED INSIGHTS​ 

May 29, 2012
The ASEAN Economic Community (AEC), which will come into effect in 2015, will integrate the region’s economies and create a single market of 600 million consumers. All industries are bracing for this change, but the competitive landscape is transforming even more quickly in the healthcare sector. Regional harmonization has already commenced for the cosmetics industry, while further integration is imminent for other industries and products, such as medical devices.
Read More
May 29, 2012
The Thai pharmaceutical industry is characterized by its expanding yet challenging landscape. Amidst growing medical tourism and strong R&D centers in the Asia Pacific region, issues related to patent protection, counterfeit drugs, and innovation recognition are increasingly imperative for pharmaceutical companies.
Read More
April 26, 2012
Three members of the Tilleke & Gibbins team have been named to The International Who’s Who of Life Sciences Lawyers 2012. Published by Law Business Research, the official research partner of the International Bar Association, this guide identifies 546 experts in 48 jurisdictions who are considered leaders in serving clients in the life sciences sector.The Tilleke & Gibbins attorneys recognized by the publication are:
Read More